BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
3.630
+0.040 (1.11%)
At close: Sep 1, 2026, 4:00 PM EDT
3.550
-0.080 (-2.20%)
After-hours: Sep 1, 2026, 7:44 PM EDT
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $31.61 million as of September 1, 2026. Its market cap has increased by 496.33% in one year.
Market Cap
31.61M
Enterprise Value
8.64M
1-Year Change
496.33%
Ranking
Category
Stock Price
$3.63
ChartMarket Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has increased from $26.00M to $31.61M, an increase of 21.56%. That is a compound annual growth rate of 3.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 31.61M | 135.86% |
| Dec 31, 2025 | 13.40M | -46.40% |
| Dec 31, 2024 | 25.00M | -73.26% |
| Dec 29, 2023 | 93.50M | 37.91% |
| Dec 30, 2022 | 67.80M | -46.74% |
| Dec 31, 2021 | 127.30M | 389.62% |
| Feb 24, 2021 | 26.00M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TransCode Therapeutics | 36.91M |
| Context Therapeutics | 35.25M |
| Quince Therapeutics | 34.33M |
| Veraxa Biotech AG | 34.04M |
| Lite Strategy | 33.36M |
| Kyntra Bio | 32.47M |
| IGC Pharma | 32.05M |
| Actinium Pharmaceuticals | 31.76M |